NZ190153A - 2-mercaptoimidazole derivatives and pharmaceutical compositions - Google Patents

2-mercaptoimidazole derivatives and pharmaceutical compositions

Info

Publication number
NZ190153A
NZ190153A NZ190153A NZ19015379A NZ190153A NZ 190153 A NZ190153 A NZ 190153A NZ 190153 A NZ190153 A NZ 190153A NZ 19015379 A NZ19015379 A NZ 19015379A NZ 190153 A NZ190153 A NZ 190153A
Authority
NZ
New Zealand
Prior art keywords
phenyl
substituted
pyridyl
unsubstituted
atoms
Prior art date
Application number
NZ190153A
Other languages
English (en)
Inventor
P G Ferrini
R Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ190153A publication Critical patent/NZ190153A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ190153A 1978-04-11 1979-04-10 2-mercaptoimidazole derivatives and pharmaceutical compositions NZ190153A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU79412 1978-04-11

Publications (1)

Publication Number Publication Date
NZ190153A true NZ190153A (en) 1981-05-15

Family

ID=19728887

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ190153A NZ190153A (en) 1978-04-11 1979-04-10 2-mercaptoimidazole derivatives and pharmaceutical compositions

Country Status (24)

Country Link
US (3) US4461770A (enExample)
EP (1) EP0004648B1 (enExample)
JP (1) JPS54135769A (enExample)
KR (2) KR820002314B1 (enExample)
AT (1) AT376971B (enExample)
AU (1) AU532402B2 (enExample)
CS (1) CS220324B2 (enExample)
CY (1) CY1302A (enExample)
DD (1) DD142712A5 (enExample)
DE (1) DE2963572D1 (enExample)
DK (1) DK148879A (enExample)
ES (5) ES8303355A1 (enExample)
FI (1) FI65066C (enExample)
GR (1) GR71193B (enExample)
HK (1) HK87285A (enExample)
HU (1) HU182018B (enExample)
IL (1) IL57040A (enExample)
MY (1) MY8600271A (enExample)
NO (1) NO148926C (enExample)
NZ (1) NZ190153A (enExample)
PL (2) PL125882B1 (enExample)
PT (1) PT69460A (enExample)
SU (2) SU1259962A3 (enExample)
ZA (1) ZA791702B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5955480A (en) * 1996-11-20 1999-09-21 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
IL132318A0 (en) * 1997-04-24 2001-03-19 Ortho Mcneil Pharm Inc Substituted imidazoles useful in the treatment of inflammatory diseases
AU8757098A (en) * 1997-06-30 1999-02-10 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de) 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) * 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SE0401653D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
CA2957667A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
US8097760B2 (en) * 2006-03-31 2012-01-17 Sunovion Pharmacuticals Inc. Preparation of chiral amides and amines
EP1894925A1 (en) * 2006-08-24 2008-03-05 Merckle Gmbh Imidazole compounds having an antiinflammatory effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
US3714179A (en) * 1970-09-08 1973-01-30 Searle & Co 1-alkyl-2-furfurylthioimidazoles and congeners
JPS5343958B2 (enExample) * 1972-07-29 1978-11-24
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4308277A (en) * 1978-08-10 1981-12-29 Ciba-Geigy Corporation 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
FI65066B (fi) 1983-11-30
ES528580A0 (es) 1985-05-01
SU1259962A3 (ru) 1986-09-23
NO148926C (no) 1984-01-11
CY1302A (en) 1985-12-06
SU991945A3 (ru) 1983-01-23
ES515766A0 (es) 1984-04-01
DE2963572D1 (en) 1982-10-21
HU182018B (en) 1983-12-28
ES528579A0 (es) 1985-05-01
ES479490A0 (es) 1983-02-01
MY8600271A (en) 1986-12-31
DK148879A (da) 1979-10-12
JPS6339594B2 (enExample) 1988-08-05
HK87285A (en) 1985-11-15
EP0004648B1 (de) 1982-08-25
IL57040A0 (en) 1979-07-25
ES528581A0 (es) 1985-05-16
EP0004648A2 (de) 1979-10-17
PL125882B1 (en) 1983-06-30
PL214745A1 (enExample) 1980-06-16
ZA791702B (en) 1980-04-30
KR820002315B1 (ko) 1982-12-17
PT69460A (en) 1979-05-01
US4584310A (en) 1986-04-22
NO791228L (no) 1979-10-12
AU4599479A (en) 1979-10-18
DD142712A5 (de) 1980-07-09
AT376971B (de) 1985-01-25
JPS54135769A (en) 1979-10-22
ES8505352A1 (es) 1985-05-16
EP0004648A3 (en) 1979-11-14
KR820002314B1 (ko) 1982-12-17
ES8303355A1 (es) 1983-02-01
ES8504738A1 (es) 1985-05-01
US4461770A (en) 1984-07-24
ES8504737A1 (es) 1985-05-01
GR71193B (enExample) 1983-04-11
FI791158A7 (fi) 1979-10-12
IL57040A (en) 1984-08-31
FI65066C (fi) 1984-03-12
CS220324B2 (en) 1983-03-25
ATA266179A (de) 1984-06-15
NO148926B (no) 1983-10-03
PL125972B1 (en) 1983-06-30
US4608382A (en) 1986-08-26
AU532402B2 (en) 1983-09-29
ES8403877A1 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
NZ190153A (en) 2-mercaptoimidazole derivatives and pharmaceutical compositions
EP0024042B1 (en) Antiinflammatory 5-substituted-2,3-diaryl-thiophenes, processes for their preparation and pharmaceutical compositions containing them
CZ219597A3 (cs) Nové sloučeniny
EP0040696A2 (en) Aminothiadiazoles as gastric secretion inhibitors
GB1587373A (en) Anti-inflammatory 1-substituted - 4,5-diaryl-2-(substituted thio) imidazoles and their corresponding sulphoxides and sulphones
US4451471A (en) Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same
US4402960A (en) Antiinflammatory imidazole derivatives
NZ200892A (en) Diaminoisothiazole-1-oxides and 1,1-dioxides
IE55484B1 (en) Dithio compounds,pharmaceutical preparations containing them and their use
CA1130288A (en) Processes for the manufacture of thio-substituted diazacycloalkenes
CA1180712A (en) Mercaptoimidazole derivatives
US4192873A (en) Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones
IE48738B1 (en) Novel mercaptoimidazole derivatives
US3922277A (en) (1-Alkyl-5-nitro-imidazolyl-2-alkyl)-pyridyl compounds
US3914248A (en) (4-Or 5-nitroimidazolyl)-imidazole compounds
NZ198074A (en) Diaryl-imidazoles,and pharmaceutical compositions
KR830000129B1 (ko) 메르캅토 이미다졸 유도체의 제조방법
KR830000130B1 (ko) 메르캅토 이미다졸 유도체의 제조방법
US4444768A (en) Pyrimido[1,6-a]indoles, pharmaceutical preparations containing them, and methods of treating pain and inflammation with them
US3996238A (en) 4- or 5-Nitroimidazoles and processes for their manufacture
CS220333B2 (cs) Způsob výroby nových derivátů merkaptoimidazolu
EP0157259A1 (de) 3-Mercapto-1,2,4-triazacycloalkadienderivate
NZ201453A (en) 1-(aryl or heteroaryl)-3,4-dihydropyrimido(1,6-a)indol-5-ylacetic acid derivatives
GB2070608A (en) Novel Amidines, Processes for their Manufacture, Pharmaceutical Preparations containing them, and their use
NZ211465A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives and pharmaceutical compositions